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Abstract
Aims. Psychiatric treatments have specific and non-specific components. The latter has been
addressed in an extensive literature on the placebo-effect in pharmacology and on common fac-
tors in psychotherapy. In the practice ofmental health care, pharmacological, psychotherapeutic
and social treatments are combined in complex interventions. This paper aims to review non-
specific components across diverse psychiatric treatments and consider implications for practice
and research.
Methods. We conducted a non-systematic review of non-specific components across psychi-
atric treatments, their impact on treatment processes and outcomes, and interventions to
improve them.
Results. The identified research is heterogeneous, both in design and quality. All non-specific
components capture aspects of how clinicians communicate with patients. They are grouped
into general verbal communication – focusing on initial contacts, empathy, clarity of commu-
nication, and detecting cues about unspoken concerns – non-verbal communication, the
framing of treatments and decision-making. The evidence is stronger for the impact of
these components on process measures – i.e. therapeutic relationship, treatment satisfaction
and adherence than on clinical outcomes – i.e. symptoms and relapse. A small number of
trials suggest that brief training courses and simple methods for structuring parts of clinical
consultations can improve communication and subsequently clinical outcomes.
Conclusions. Methodologically, rigorous research advancing current understandings of non-
specific componentsmay increase effectiveness across different treatments, potentially benefitting
large numbers of patients. Brief training for clinicians and structuring clinical communication
should be used more widely in practice.
Introduction
Various treatments have been established in psychiatry, based on different ideas, approaches
and methods. They are usually classified as biological, psychological and social, with each
category containing a wide range of treatments. These treatments consist of specific and non-
specific components. The specific components are defined by the theoretical model for how
and why the given treatment is effective.
In addition to these specific components, there are also other components that may have a
therapeutic effect. For example, the way treatments are presented to patients may fill them with
optimism resulting in more positive engagement and improved mood (Thomas, 1987). The sug-
gestion of improvement can raise expectations that then become self-fulfilling (Krell et al., 2004),
and the respectful attention of clinicians may raise patients’ self-esteem, and help them to
overcome their distress (Robson, 1988). All these components that are not captured by the
theoretical model but can still have a therapeutic effect are considered non-specific.
In psychiatry, there is a long history of considering non-specific treatment components,
and the term ‘non-specific’ itself has occasionally been used in the literature since the 1960s
(Honigfeld, 1964; Rickels, 1968). However, most of the psychiatric literature has used other
terms. An extensive literature addresses non-specific components in psychopharmacology
using the concept of placebo (Benedetti, 2008; Kirsch, 2014; Weimer et al., 2015), and in psy-
chotherapy considering them as common factors across different schools (Huibers and
Cuijpers, 2015; McAleavey and Castonguay, 2015; Wampold, 2015; Cuijpers et al., 2019). In
contrast, there is little literature discussing non-specific components in social interventions.
In routine psychiatric care, pharmacological, psychological and social treatments are not
delivered in isolation but are variably combined in complex interventions. This raises the ques-
tion as to which components are non-specific across different treatments and how clinicians
can utilise such components to improve outcomes across interventions, potentially benefitting
large numbers of patients. We, therefore, conducted a review of non-specific components that
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have been shown to be associated with treatment uptake, satisfac-
tion, adherence and outcomes across treatments and also reviewed
the evidence for interventions to improve those components. The
review focuses on what clinicians can do and say in treatment.
It, therefore, uses the term treatment ‘components’. It avoids the
frequently used term ‘factors’ which can imply treatment compo-
nents, but also mediating processes and constructs about what
may be going on in clinicians’ and patients’ minds such as
attitudes, beliefs and experiences.
Methods
We conducted a non-systematic review of the literature. A system-
atic search was not appropriate because a search term ‘non-
specific’ would have been too restrictive and miss relevant litera-
ture that would not use the term, whilst including other search
terms such as ‘placebo’ and ‘common factors’ across treatments
would have yielded an unmanageable amount of literature. We,
therefore, followed the approach suggested for conceptual reviews
with (a) a wide search of disparate databases and sources, (b) for-
ward and backward citation tracking, (c) safeguards against
potential biases by using a team of researchers with different
backgrounds and (d) some overlap of the searching, analysing
and writing-up stages of the review (Lilford et al., 2001).
The synthesis was narrative and conducted in an iterative
process by a team with a clinical-academic psychiatrist (SP) and
three research psychologists at different career stages, educated
in different countries.
Results
All non-specific components identified in the review capture
aspects of how clinicians communicate with patients. They fell
into the groups of general verbal communication, non-verbal com-
munication, treatment framing and decision-making. Research
evidence is first presented for these components and then for inter-
ventions to improve clinical communication.
General verbal communication
Extensive evidence shows that a more positive patient–clinician
relationship is associated with better adherence and more favour-
able clinical outcomes across treatments (Fenton et al., 1997;
Johansson and Jansson, 2010; Priebe et al., 2011a; McAleavey
and Castonguay, 2015; Wampold, 2015; Berry et al., 2016;
Green, 2017; Shattock et al., 2018; Strauss et al., 2018).
Clinicians cannot directly control or vary the relationship, but
they can influence it. The way to shape and change it is through
communication. Communication can be very brief, as it is in an
emergency, or occupy many hours, as in psychotherapy, and prin-
ciples of good clinical communication in psychiatry have been
suggested in the literature (Priebe et al., 2011b). Different clini-
cians achieve different treatment outcomes even if they prescribe
the same medication (McKay et al., 2006) or provide the same
type of psychotherapy (Crits-Christoph et al., 1991; Castonguay
and Hill, 2017). Much of this variance in treatment outcomes is
likely to be due to how they communicate with patients.
Good communication matters right from the very first contact.
How psychiatrists introduce themselves can already make a
difference. In an experimental study, patients preferred an intro-
duction with an explanation about what to expect in the first con-
sultation over brief introductions without explanation or longer
introductions in which clinicians disclosed personal problems
(Priebe et al., 2013). More research on the initial consultations
has been conducted within primary care demonstrating the ben-
efits of clear messages. In a randomised controlled trial (RCT)
with patients with medically unexplained symptoms, a General
Practitioner (GP) either gave a firm diagnosis with a positive
prognosis or provided neither diagnosis nor prognosis (Thomas,
1987). Patients receiving the former message showed greater
symptom improvement regardless of whether they received any
treatment or not. In another RCT, patients with no definite diag-
nosis were randomly assigned to either a directive or a sharing
style of communication. In the directive communication group,
the GP made definitive statements about diagnosis, treatment,
prognosis and follow-up. In the latter, the physician asked for
the patient’s opinion about the problem, treatment and diagnosis.
Patients receiving a directive style of communication were more
satisfied (Savage and Armstrong, 1990). In a similar patient
group, the physician either provided a firm diagnostic label and
prescribed medication, which was actually a placebo, or told the
patient that there was no evidence of disease and that they did
not require treatment (Thomas, 1978). Both groups were given
clear, albeit very different, information about diagnosis and
their prognosis and had similar outcomes. The two studies sug-
gest that the content of some types of information may be less
important than the way it is presented.
Beyond the initial consultation, a central component of bene-
ficial clinical communication is empathy which concerns sensing
patients’ emotions and concerns and making them feel under-
stood (Rickels et al., 1971; Elliott et al., 2018). A systematic review
of the effect of empathy in healthcare consultations found that
increased clinician empathy positively impacted on patients’
pain, anxiety and satisfaction (Howick et al., 2018). Qualitative
studies underline the importance of clinicians’ empathy in psych-
iatry, and the related concept of positive regard has been shown to
be linked with better outcomes in psychotherapy (Johansson and
Eklund, 2003; Ljungberg et al., 2015; Ross and Watling, 2017).
A number of studies of video-recorded consultations have
studied the empathy of psychiatrists in more detail and high-
lighted how they detect and respond to patients’ hints about
their concerns (Rimondini et al., 2006; Zimmermann et al.,
2007; Del Piccolo et al., 2012; Xanthopoulou et al., 2018).
Picking up on hints, as opposed to ignoring them or changing
the topic, seems to strengthen the therapeutic relationship. Even
the type of questions that clinicians use to elicit patient concerns
appears relevant. Questions that propose an understanding of
patients’ experiences may be appreciated as a display of empathy
and are linked with more positive relationships (Thompson et al.,
2016).
Non-verbal communication
Communication with patients is not solely verbal. Non-verbal
behaviour, including posture, rate of speech, intonation and pitch
of voice are critical in interpreting the meaning of verbal utterances
and can convey additional messages. Non-verbal communication
appears to be particularly relevant for showing that the clinician
is listening, taking the patient seriously, demonstrating empathy
and establishing a positive rapport (Beck et al., 2002).
Most research on non-verbal behaviour has been observa-
tional, exploring associations with patient satisfaction and treat-
ment outcomes. One systematic review suggests that non-verbal
indicators of clinician warmth and clinician listening are linked
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with greater patient satisfaction (Henry et al., 2012). Another
study found that patients were more likely to attend their follow-
ing appointment when their psychiatrists’ tone of voice had been
more positive (Cruz et al., 2013).
Communication, including non-verbal communication, is
reciprocal. The non-verbal behaviour of psychiatrists and patients
with schizophrenia during a consultation has been shown to be
linked: when psychiatrists showed more pro-social behaviour in
the form of gestures and open posture – inviting rather than
avoiding interaction – patients reciprocated. This was associated
with higher patient satisfaction and lower symptom levels
(Lavelle et al., 2015). In psychotherapy, more co-ordination in
patients’ and clinicians’ body movements, as assessed by auto-
mated analyses of videotapes, was associated with more positive
therapeutic relationships and higher patient self-efficacy
(Ramseyer and Tschacher, 2011). Thus, empathy can be rated
in clinicians’ speech and is also communicated in clinicians’ non-
verbal behaviour.
Non-verbal clinical communication has been investigated also
in experimental designs. A study of actors pretending to be clin-
icians found that manipulating gaze and body orientation had a
significant effect on how empathetic participants perceived their
clinicians to be (Brugel et al., 2015). In progressive relaxation
training for anxious women, therapists manipulated their voice
volume, pitch and rate of speech. When the therapist decreased
the tone, volume and rate of speech throughout the session, the
patients were more relaxed (Knowlton and Larkin, 2006).
Treatment presentation and framing
Patient expectation has consistently been linked to variation in
clinical outcome across a range of medical disciplines, including
psychiatry (Carver and Dunham, 1991; Safren et al., 1997;
Mondloch et al., 2001). As with the therapeutic relationship, the
beliefs and expectations of patients cannot be controlled by clin-
icians. However, they may be influenced by communication, espe-
cially by how treatment is presented (Glare et al., 2018). This is
often referred to as framing and it can be manipulated in experi-
mental research. A common way of framing treatment is for the
clinician to tell a patient that the treatment has a 30% chance
of success (gain frame) or alternatively that it has a 70% chance
of failure (loss frame) (Levin et al., 2002; Moxey et al., 2003;
O’Keefe and Jensen, 2007).
The majority of studies assessing the effect of treatment fram-
ing across different psychiatric conditions have focused on help-
seeking behaviours and on the uptake of treatment. Findings
from these studies have been mixed (O’Keefe and Jensen, 2007;
Lueck, 2017) with more positive findings on treatment uptake
than subsequent adherence (Mavandadi et al., 2017, 2018).
Prospect theory may help explain this divergence (Tversky and
Kahneman, 1979; Rothman et al., 2006). It suggests that indivi-
duals avoid risky behaviours when they are prompted to consider
the potential gains. In contrast, individuals are more prepared to
engage in risk-taking behaviour when prompted to consider pos-
sible loss. In terms of mental health care, it has been suggested
that help-seeking is not risk-neutral (Lueck, 2018). Attending
an initial appointment could result in a stigmatised diagnosis or
in long-term treatment (Rothman et al., 2006). As a consequence,
highlighting the potential losses associated with non-attendance
by using a negative treatment frame may be more effective. In
contrast, for individuals who do not perceive mental health treat-
ment as risky, such as patients already in treatment, emphasising
the benefits of behaviour through a positive treatment frame may
be more effective.
In addition to presenting a specific positive or negative treat-
ment frame as discussed above, clinicians can express their opti-
mism or scepticism about treatment in more general terms. An
experimental study using video-clips of real psychiatrists manipu-
lated how optimistic or sceptical they were about a possible
pharmacological or psychological treatment. Patients who were
newly referred to mental health services preferred an optimistic
treatment presentation. However, this was not the case for
patients who had already been in psychiatric services for more
than 2 years and had experienced that treatments in psychiatry
are not always, at least not for them, a resounding and lasting suc-
cess (Priebe et al., 2017a). Thus, the impact of clinician optimism
or scepticism is likely to vary depending on patients’ characteris-
tics and experiences.
Decision-making
Decision-making is central to most psychiatric treatment encoun-
ters, often relating to starting, reviewing or changing pharmaco-
logical or other treatments. Involving patients in the
decision-making process is widely regarded as good clinical prac-
tice (NICE, 2011). The level of patient involvement depends
mainly on clinicians’ communication, as it requires informing
patients, eliciting their preferences, discussing the pros and cons
of different treatments and incorporating their preferences
where possible into the decision (Edwards et al., 2010).
Much of the recent literature uses the concept of shared
decision-making which suggests that decisions about treatment
should be arrived at in a shared and non-directive discussion
between patient and clinician (Hamann et al., 2003; Slade, 2017).
More patient involvement in treatment decisions has been linked
to symptom improvements and reduced substance misuse. This
applies to patient groups with different diagnoses and in different
settings, including primary care and inpatient treatment (Clever
et al., 2006; Deegan and Drake, 2006; Hamann et al., 2006, 2017;
Shay and Lafata, 2015; Perestelo-Perez et al., 2017). Systematic
reviews found that patients with bipolar disorders want more
involvement in treatment decisions, and more involvement is asso-
ciated with better adherence, higher patient satisfaction and lower
suicidal ideation (Fisher et al., 2016). In dementia, patients who
were less involved in decisions about whether to start medication
at the point of diagnosis were less satisfied than those who were
more involved (Dooley et al., 2018).
Improving communication with involuntary patients may be
particularly challenging (Thornicroft et al., 2013; Giacco et al.,
2018a, 2018b). Research on this is limited but encouraging.
Involving patients in treatment decisions and planning from the
very first days of involuntary hospitalisation onwards was found
to be feasible and valued by patients (Burn et al., 2019). An inter-
vention combining components of shared decision-making with
psychoeducation was reported to reduce re-hospitalisation rates
in a RCT (Lay et al., 2017).
However, the precise preferences of patients for how decisions
should be made can vary depending on patient characteristics,
therapeutic situations – e.g. an acute emergency and a consult-
ation in long-term treatments – and types of treatment (De Las
Cuevas et al., 2013). For example, some patients want to be
more involved in the decision-making process about psychosocial
interventions than about which medication they are prescribed
(Roter et al., 1997). To capture the variation of how patients
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want to be involved in decisions in a given situation, the OPTION
scale has been developed (Elwyn et al., 2003). So far it has been
applied more in general practice than in psychiatry, and where
it has been used in psychiatry, patient involvement has been
found to be very low regardless of their wishes (Goss et al.,
2008). A related concept to involvement in decision-making is
agreement about treatment. A review of effective clinician-patient
communication in healthcare reported positive associations
between patient-clinician agreement and patient outcomes
(Stewart, 1995).
Interventions to improve clinical communication
The importance of clinical communication raises the question of
how clinicians’ communication can be improved to make treat-
ments more effective. Communication may be influenced through
training or through interventions which structure communication
during consultations, or both.
A Cochrane review of communication training in the context
of severe mental illness in psychiatry identified only one RCT
in this area (Papageorgiou et al., 2017). In a four-session training
course, psychiatrists treating patients with psychosis practiced
their communication skills with actors and listen to voices mim-
icking hallucinations on headphones whilst performing various
tasks. The focus is on developing a shared understanding of
symptoms, addressing positive and negative symptoms, empower-
ing patients through agenda-setting and involving them in
decision-making. The training led to improved observer-rated
communication and more positive therapeutic relationships
(McCabe et al., 2016).
In a primary care study, training in the form of structured dis-
cussions was tested to help clinicians elicit concerns from parents
and children and to raise their treatment expectations. Three
1-hour discussions around video examples of family-clinician
communication were followed by practice sessions with patients
and self-evaluation. The training reduced the distress of parents
and for some children, impairment across a range of disorders
(Wissow et al., 2008). Another brief training focused on non-
verbal behaviour. Clinicians recorded their own consultations in
routine practice and reflected on three things they wanted to
change in their non-verbal communication. Clinicians reported
that the areas for improvement were apparent after watching
fewer than five consultations. They focused on not interrupting
the patient, attentive listening through feedback and looking at
the patient rather than their medical notes. The training improved
patient satisfaction and reduced distress (Little et al., 2015).
An alternative to training practitioners is to modify the struc-
ture of clinician-patient communication. Some interventions
focus on improving decision-making through the use of decision
aids. They are typically checklists assessing patients’ preferences
and providing information about available treatments. They are
intended to help patients and clinicians arrive at a treatment deci-
sion. A Cochrane review of the effects of decision aids in people
facing treatment decisions across medicine identified 105 studies
covering over 31 000 participants (Stacey et al., 2017). Yet, the
evidence for their effect on treatment outcomes in psychiatry is
limited. Two cluster RCTs looking at the effect of decision aids
aimed at improving shared decision-making with patients with
depression and post-traumatic stress disorder found mixed
results. Both studies failed to find effects on medication adherence
or on symptom improvement, but the decision aid improved
patients’ treatment satisfaction and perceived involvement in
decision-making (Mott et al., 2014; LeBlanc et al., 2015). An
online decision aid informing young patients with depression
about treatment options was tested in an RCT. It found higher
treatment adherence and lower symptoms as compared to treat-
ment as usual (Perestelo-Perez et al., 2017). Another similar
online decision aid was assessed in a pre-post design. It was linked
with improved knowledge of treatment options and less conflict
with the clinician during the decision-making process
(Simmons et al., 2017).
There are a small number of interventions to structure part of
the patient-clinician meeting and directly guide communication.
Focusing on 20 common needs, a communication checklist asks
patients before a consultation to indicate the areas they want to dis-
cuss with their psychiatrist (Van Os et al., 2004). The checklist was
found to improve the quality of patient-psychiatrist communica-
tion and induced changes in management immediately after the
intervention. A more detailed method for structuring communica-
tion is DIALOG + (Priebe et al., 2015, 2017b), which is based on
the quality of life research, concepts of patient-centred communi-
cation, and principles of solution-focused therapy. In their meet-
ings with clinicians, patients rate their satisfaction with eight life
domains and three treatment aspects, assisted by a graphical dis-
play on a tablet. Patients then decide which domain(s) to discuss
in the given meeting. Each of the patient’s concerns is then
addressed in a four-step approach – understanding, looking for-
ward, exploring options and finally agreeing on actions. In a cluster
RCT, the use of DIALOG + regularly over a 6-months period
improved outcomes and reduced treatment costs.
Discussion
Although much less research in psychiatry has explored non-
specific than specific treatment components, an increasing body
of evidence highlights the importance of such components across
treatments. The existing evidence suggests that the way clinicians
generally communicate with patients both verbally and non-
verbally, and how they frame treatments and involve patients in
the decision-making process can influence uptake, adherence
and outcomes of treatments. Overall, there is more evidence for
the impact of non-specific components on process measures,
such as satisfaction and adherence, than on clinical and social
outcomes of treatments.
The summarising nature of our review did not consider the
methodological quality of the referenced studies. While the review
included some high-quality RCTs and meta-analyses, overall the
studies are heterogeneous in their design and quality. Many stud-
ies were exploratory in nature and the results should be inter-
preted with caution. Moreover, we did not specify effect sizes.
Most studies of non-specific components were intended to estab-
lish only that the given component is relevant in principle. Hardly
any studies were designed and implemented with sufficient rigour
to determine the effect sizes.
Future research
Future research should go beyond establishing the effects of
widely acknowledged non-specific components. There is no
need for further studies showing that patients are more likely to
come back for the next appointment if their clinician shows
empathy and addresses their concerns. What is required is
research that advances our understanding of non-specific compo-
nents and the underlying mechanisms. This may include
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experimental studies with clinical and non-clinical samples that
test the effects of varying such components in ways that would
be feasible in clinical practice.
In RCTs, one might try to standardise the delivery of at least
some non-specific components, in both the experimental and
control groups. If achieved, this should reduce the variance in
outcomes and therefore help to detect the effects of the specific
treatment components being tested.
In addition, research should aim not only to understand
non-specific components better but also to utilise them more
effectively. The few studies on improving clinical communication
indicate that such improvements are possible and can lead to
better outcomes.
Much research on psychiatric treatments has focused on find-
ing patient characteristics that predict a positive response to spe-
cific treatment methods. Recently, such efforts have sometimes
been referred to as personalised medicine. For non-specific com-
ponents, individual responsiveness may possibly vary even more
than for specific ones. Which characteristics of the patient and
context determine how best to communicate with the patient
remains largely unknown. The literature provides some hints
about patient characteristics and experiences predicting different
responses to placebo or optimistic treatment framing (Bialik
et al., 1995; Holmes et al., 2016). Yet, much more detailed
research is required, and the categories often used in research,
such as diagnoses, may not be very helpful for this.
Implications for practice
Non-specific components are part of all treatments in practice,
with one review suggesting that they explain up to 60% of the
variance in outcomes (Walach et al., 2005). When clinicians com-
municate with patients it can always have an effect. This effect can
be positive, but it can also be detrimental, which is sometimes
referred to as a nocebo effect (Benedetti et al., 2007; Evers
et al., 2018). Non-specific components should therefore not be
ignored or devalued, but rather embraced and emphasised as a
major part of what clinicians can do to help patients (McQueen
and Smith, 2012).
Communication skills are important for all clinicians working
in mental health care. Short and effective training courses exist
and could be rolled out into routine care at limited costs.
Another simple and even less expensive option for refining com-
munication skills is video-recordings of consultations to review
what works and what may be improved. Yet, neither training
nor reviews of video-recordings are widely used in routine care.
Beyond that, a focus on communication skills may have positive
implications for clinicians working in psychiatric care. Improving
communication skills will require more training and supervision,
but might also be an opportunity to strengthen the specific profes-
sional profile of clinicians in psychiatry. Clinicians in routine psy-
chiatric care are expected to engage and communicate with patients
in widely varying settings and treatment situations. These include
acute crises, involuntary treatment or long-term rehabilitation,
with variable time frames and changing treatment goals. The chal-
lenge for clinicians is to develop and flexibly utilise a repertoire of
skills to achieve the optimal benefit for the patient. These skills are
likely to vary across individuals and be influenced by personal
styles and individual strengths so that much of the training will
have to be individualised. Yet, such training may provide clinicians
in psychiatry with a relatively unique skill-set and strengthen their
professional expertise.
Conclusions
Over the last four decades, extensive research on specific treat-
ment components has led to only limited improvement of effects
of psychiatric treatments. A stronger focus on non-specific treat-
ment components in both practice and research may improve the
effectiveness of complex interventions with pharmacological,
psychological and/or social approaches. This would potentially
benefit large numbers of patients across settings and treatment
methods and therefore have a substantial public health effect
beyond the improvement of confined specific treatment
components.
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